the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences

Biotechnology Market Research

<< Previous Page:   1   2   3   4   5   6   7   8   9   10   11   12   Next >>

Reports

European Lab-on-chip and Microfluidics Markets
Table of Contents Published: 2009/05 Published by: Frost & Sullivan
This research service gives a detailed analysis of the lab-on-chip and microfluidics market in Europe from 2005-2015. ...

Immune/Inflammatory Disease: Early-Stage R&D Technologies and Dealmaking
Table of Contents Published: 2009/05 Published by: Decision Resources, Inc.
Today' s leading autoimmune/infl ammatory disease drugs are blockbusters, but what are the remaining unmet needs and next opportunities? Dealmaking patterns indicate that Big Pharma continues to look to small technology companies to tap opportunities to t ...

In Vitro Diagnostics in a Recessionary Economy: IVD Market Forecasts, Analysis and Success Strategies
Table of Contents Published: 2009/05 Published by: Kalorama Information
It is commonly asserted that in vitro diagnostics is a recession-proof industry. Kalorama Information' s lead diagnostic analyst Shara Rosen tests that assumption and provides strategic conclusions in Shara Rosen' s new report In Vitro Diagnostics in a Re ...

In Vitro Diagnostics Market Analysis 2009-2024
Table of Contents Published: 2009/05 Published by: Visiongain
In vitro diagnostics constitute an important, growing healthcare industry and market, one that is increasingly biotechnological and closely aligned with pharma. ...

Innovations in Protein Kinase Therapies: Company pipelines, therapeutic applications and market forecasts
Table of Contents Published: 2009/05 Published by: Business Insights
Kinases are a ubiquitous group of enzymes that catalyze the phosphoryl transfer reaction from a phosphate donor (usually ATP) to a receptor substrate, which can be protein, lipid, or a small molecule (e.g. sugar). Phosphorylation of protein substrates is ...

Monoclonal Antibodies in Cancer Therapy 2009-2024
Table of Contents Published: 2009/05 Published by: Visiongain
Monoclonal antibody-based therapies for cancer are a thriving part of the biotechnology sector, as our new market report explains. The oncology market continues to expand worldwide, with high demand for more-efficacious and better-tolerated cancer therapi ...

Opportunities in Predictive Drug Discovery and the Use of In-Silico Tools
Table of Contents Published: 2009/05 Published by: Frost & Sullivan
This short issue based research provides a top level picture of the applications of in-silico tools within the drug discovery market in Europe. ...

SPECIAL REPORT: Riding the Biotech Economic Tsunami - Surfing to Safety or Wipeout?
Table of Contents Published: 2009/05 Published by: Decision Resources, Inc.
In 2008, the global financial crisis radically altered the dynamics of the biotech industry; many weaker companies will fail. However, private investment in biotech continued, and pharmaceutical companies invested significant sums in acquiring and partner ...

Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
Table of Contents Published: 2009/05 Published by: Datamonitor
As a result of the increasing switch from live-attenuated and killed whole-cell vaccines to subunit antigens, there is a need for novel antigen delivery technologies to improve vaccine efficacy and safety. This report assesses key strategies, technologies ...

Strategic Analysis of the European Markets for Theranostics
Table of Contents Published: 2009/05 Published by: Frost & Sullivan
This strategic analysis service provides a detailed analysis of the European theranostics market. An indepth analysis of marketing parameters coupled with competitive factors and strategies for sustained market prevalence are reported. ...

The Immune/Inflammatory Pipeline: A Strategic Review
Table of Contents Published: 2009/05 Published by: Decision Resources, Inc.
The current immune/inflammatory pipeline is over 375 drugs strong, with approximately 250 companies involved in these agents' development. Yet, despite this robust pipeline size, Decision Resources analysts do not believe that any one agent in development ...

The Market for Antibodies: Keys to Success for Commercial Suppliers, Vol. III
Published: 2009/05 Published by: BioInformatics, LLC
The Market for Antibodies: Keys to Success for Commercial Suppliers, Volume III will help suppliers better understand how antibodies are used and how demand is impacted by scientific application. In addition, segmentation analysis and trend comparisons wi ...

The World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition
Table of Contents Published: 2009/05 Published by: Kalorama Information
This Kalorama Information report - The World Market for Cancer Therapeutics and Biotherapeutics - focuses on several segments for cancer treatment. The report covers both currently marketed and late stage development cancer products. Revenues for each cur ...

Therapeutic Peptides in Oncology - Favorable Conditions But Where to Commercialize?
Table of Contents Published: 2009/05 Published by: BioSeeker Group AB
The discovery of new cancer therapeutics has seen a significant shift towards biologicals as an alternative to small molecule drugs. Alternative binding peptide molecules, derived from combinatorial scaffold libraries, are now challenging traditional anti ...

US Markets for ENT and Bronchoscopy Devices 2009
Table of Contents Published: 2009/05 Published by: Millennium Research Group
The US markets for ear, nose, and throat (ENT) and bronchoscopy devices will grow moderately through 2013. The ENT market will be far larger than the market for bronchoscopy devices and will also expand more rapidly, reaching a value of more than $360 mil ...

US Stem Cell Market Analysis
Table of Contents Published: 2009/05 Published by: RNCOS E-Services Pvt. Ltd.
US Stem Cell Market Analysis provides extensive research and thorough analysis of the current industry trends driving the growth of stem cell market in the US. This report highlights the emerging segments in the market alongwith their market potential to ...

Biosimilars and Follow-On Biologics Report: The Global Outlook 2009-2024
Table of Contents Published: 2009/04 Published by: Visiongain
The complexity of biologic drugs has retarded development of regulatory frameworks for approval of biosimilars in many countries. The EU was the first major regulatory authority to adopt a procedure allowing regulatory approval of biosimilar medicines. Th ...

Bone Grafts
Table of Contents Published: 2009/04 Published by: Global Industry Analysts, Inc.
This report analyzes the US market for Bone Grafts in Millions of US$. The market for Bone Grafts is analyzed by the following segments: Standard Allografts, Machined Bone Allografts, Demineralized Bone Matrix (DBM), Bone Morphogenetic Protein (BMP), Plat ...

Capitalizing on New Opportunities for Stem Cell Products
Table of Contents Published: 2009/04 Published by: BioInformatics, LLC
Capitalizing on New Opportunities for Stem Cell Products provides a roadmap for stem cell product suppliers to help navigate a landscape that is poised for change- and growth. This analysis was designed to guide suppliers in redirecting resources to new a ...

Chinese Markets for Antibiotics
Table of Contents Published: 2009/04 Published by: Asia Market Information & Development Co.
China' s demand for Antibiotics has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry development, supply a ...

Choices in Cord Blood Banking: Factors Influencing Parental Decision-Making
Table of Contents Published: 2009/04 Published by: BioInformant
Cord blood banking is increasingly being used to improve and save lives. Stem cells derived from umbilical blood have been used in more than 14,000 transplants worldwide to treat a wide range of blood diseases, genetic and metabolic disorders, immunodefic ...

Companion Biomarkers in Drug Development
Table of Contents Published: 2009/04 Published by: Trimark Publications
This TriMark Publications report describes new biomarker technology platforms developed for the analyses of drug targets that are connected to the effectiveness of therapeutic agents in a clinical setting. ...

Dealmaking and Industry Outlook: Therapeutic Antibodies and Vaccines for Cancer
Table of Contents Published: 2009/04 Published by: Decision Resources, Inc.
Targeted cancer therapies have achieved phenomenal growth, and many MAb-based immunotherapies are blockbusters or mega-blockbusters. This market success is due not only to these MAbs' ability to treat unmet need in many cancers but also to the high cost o ...

European Markets for Orthopedic Biomaterials 2009
Table of Contents Published: 2009/04 Published by: iData Research Inc.
In 2008, the combined European biomaterial market was worth ?271.4 million. This includes hyaluronic acid viscosupplements, bone graft substitutes, BMP growth factors, autologous chondrocyte implantation and platelet/bone marrow concentration systems. Wit ...

Medical Biosensors Market 2008-2012
Table of Contents Published: 2009/04 Published by: Infiniti Research Limited
A biosensor is a device which makes use of biological substances to indicate the absence or presence of a particular substance in the tested material. ...

Nucleic Acid Testing: A Vehicle for Advancing Personalized Medicine
Table of Contents Published: 2009/04 Published by: Decision Resources, Inc.
One of the fastest-growing segments of molecular diagnostics is nucleic acid testing (NAT). NAT is central to the life sciences industry, to improved healthcare, and to personalized medicine. Tools based on NAT are used to discover new biomarkers and deve ...

Pharmacodiagnostics and Personalized Medicine 2009 (Markets, Challenges, Forecasts and Key Players)
Table of Contents Published: 2009/04 Published by: Kalorama Information
Pharmacodiagnostics are considered the pathway to what has been termed personalized medicine, the use of molecular analysis to achieve optimum medical outcomes in the management of a patient' s disease or predisposition to disease. ...

Practical Guide to Finding Partners in Pharma and Biotech, 2nd edition
Table of Contents Published: 2009/04 Published by: CurrentPartnering, a division of Wildwood Ventures Limited
CurrentPartnering' s Practical Guide to Finding Partners in Pharma & Biotech provides a comprehensive overview of all the steps required to identify and secure partnering either for an in-licensing or out-licensing activity. The report takes the reader th ...

Promising Biotech Companies in Europe
Table of Contents Published: 2009/04 Published by: Frost & Sullivan
This research service aims to profile some of the promising biotech companies in Europe across different countries and segments. ...

Stakeholder Opinions: Hematopoietic Stem Cell Transplantation - In need of further research and development
Table of Contents Published: 2009/04 Published by: Datamonitor
Hematopoietic stem cell transplantation (HSCT) has evolved considerably over the past 50 years, driven by developments in stem cell sources, donor identification and conditioning regimens. Nowadays, it has a range of applications, including the treatment ...

The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
Table of Contents Published: 2009/04 Published by: Business Insights
This report examines the portfolio sales performances, pipelines and growth strategies of each of the top 10 biosimilars companies. The opportunities and threats facing each of these leading players are also assessed. This report also examines the size, g ...

Who's Doing What in Molecular Diagnostics? - The Results of the Kalorama Information/Emmes Group Survey of U.S. Laboratories
Table of Contents Published: 2009/04 Published by: Kalorama Information
From Kalorama Information a unique tool for assessing the diagnostic business today. Working in conjunction with premier diagnostic survey database Emmes Group, Kalorama Information presents the summarized results from a recent survey of a critical mass o ...

Ankylosing Spondylitis: How Have Biological Therapies Affected the Market?
Table of Contents Published: 2009/03 Published by: Decision Resources, Inc.
The availability of TNF-ƒ¿ inhibitors fueled a tremendous year-on-year increase in the ankylosing spondylitis (AS) market from 2006 to 2007, and we expect significant growth to continue over the next ten years. Although these agents may establish themselv ...

Assessment of Innovations in Biochips
Table of Contents Published: 2009/03 Published by: Technical Insights, Inc.
This research service discusses the assessment of innovations in biochips. ...

Bioinformatics Markets
Table of Contents Published: 2009/03 Published by: Trimark Publications
The life science informatics marketplace--known as bioinformatics--is set to expand as high-tech companies infiltrate this arena and biopharmaceutical companies incorporate key informatic solutions into their business strategies. TriMark Publications beli ...

Biopharma Quarter: Key Trends and Events of the Fourth Quarter of 2008
Table of Contents Published: 2009/03 Published by: Decision Resources, Inc.
2008 came to a close amid political transition in the world' s largest pharmaceutical market and economic upheaval in all of the world' s markets. Our review of key events that occurred in the fourth quarter and prominent trends at play in that time frame ...

Dealmaking and Business Strategies in the Age of Personalized Medicine
Table of Contents Published: 2009/03 Published by: Decision Resources, Inc.
The promise of personalized medicine is having a profound impact on the healthcare industry. It promises to change the way healthcare is delivered and how drugs and diagnostics are developed. Pharma companies are still worried. ...

Direct-To-Consumer Genetic Testing: Business Prospects in the United States Overview
Table of Contents Published: 2009/03 Published by: Insight Pharma Reports
The current marketplace for direct-to-consumer (DTC) genetic testing is very dynamic and fluid. At least 42 DTC genetic testing companies have been identified to date, and additional market entrants are likely. Firms marketing and selling genetic tests DT ...

Evolving Trends in Biopharmaceutical Licensing: Deal assessments, drivers and resistors
Table of Contents Published: 2009/03 Published by: Business Insights
This report provides a detailed analysis of licensing strategies in the biopharmaceutical industry over the 2001-08 period and draws upon the growth of the biopharmaceutical industry, deal-making trend data, drivers and challenges facing biopharmaceutical ...

Insights into Platform Technology and Early-Stage Pipeline Mergers and Acquisitions
Table of Contents Published: 2009/03 Published by: Decision Resources, Inc.
The continuing activity in mergers and acquisitions (M&As) involving biotechnology companies refl ects the industry' s growth and maturity. Biotech companies are increasingly merging for strategic reasons that include business, clinical, and technological ...

Know the Other "Omics": Exploring Drug and Diagnostics Development Through Proteomics
Table of Contents Published: 2009/03 Published by: Decision Resources, Inc.
Genomics has paved the way for its cousin, proteomics, to secure its share of the omics hype. Researchers look to proteomics to deliver on the promise to assess the viability of drug targets for monitoring disease progression, optimizing disease managemen ...

Liquid Chromatography Markets (LC, HPLC and UHPLC)
Table of Contents Published: 2009/03 Published by: Kalorama Information
The liquid chromatography (LC) market has been relatively mature for quite a while, with a slow evolution of products and applications over the last few decades. High performance liquid chromatography (HPLC) has used essentially the same types of componen ...

Mesenchymal Stem Cells, Advances & Applications
Table of Contents Published: 2009/03 Published by: BioInformant
This market research report focuses on recent advances in MSC research applications, explores research priorities by market segment, highlights individual labs and end-users of MSC research products, explores the competitive environment for MSC research p ...

Opportunities in Human Embryonic Stem Cell (hESC) Product Development
Table of Contents Published: 2009/03 Published by: BioInformant
Human embryonic stem cells (hESCs) are stem cells derived from the inner cell mass of a blastocyst, which is a stage reach 4-5 days post fertilization. hESCs are the most pluripotent of all stem cell types and can develop into over 200 different cell type ...

Option & Evaluation Agreements in Pharma and Biotech
Table of Contents Published: 2009/03 Published by: CurrentPartnering, a division of Wildwood Ventures Limited
The Option and Evaluation Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies. ...

Prospering in a Down Market: Strategies for Life Science Suppliers
Table of Contents Published: 2009/03 Published by: BioInformatics, LLC
This report will help life science suppliers weather the financial storm of 2009. Pharmaceutical, biotechnology, academic and government labs are bracing for budget freezes and staff reductions. Use this report to understand how scientists plan to control ...

Stakeholder Insight: Psoriasis - Biologics are yet to make topical treatments obsolete
Table of Contents Published: 2009/03 Published by: Datamonitor
Patient perception of disease severity drives treatment-seeking behavior in psoriasis. New therapeutic options targeting specific mechanisms are set to reshape severe psoriasis therapy. However, current biologics have not undermined first-line topical the ...

Stakeholder Opinions: Cystic Fibrosis - A pipeline full of hope
Table of Contents Published: 2009/03 Published by: Datamonitor
With cystic fibrosis patients still dying prematurely and only two products currently approved for the treatment of this disease, the market is wide open for new entrants. Not only will novel symptomatic treatments and re-formulations lead to improved tre ...

Stakeholder Opinions: Physician perception of biologics in Autoimmune Disease - Targeted detailing is the key to success
Table of Contents Published: 2009/03 Published by: Datamonitor
Factors influencing a prescribing decision can diverge from clinical facts. In the highly competitive autoimmune area, misconceptions and physician habits can result in loss of sales. Targeted detailing of specialist physicians, differentiating by indicat ...

Stem Cell Research Products: Opportunities, Tool, & Technologies
Table of Contents Published: 2009/03 Published by: BioInformant
BioInformant' s latest market report, Stem Cell Research Products: Opportunities, Tools & Technologies, published March 2009, is creating quite a buzz in the industry. The report was produced using a detailed end-user survey of research scientists, in whi ...


<< Previous Page:   1   2   3   4   5   6   7   8   9   10   11   12   Next >>

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.